Clinical Trial Update: Ultrasound and EMG Guided Botox Injection for the Treatment of Non-Relaxing Puborectalis Syndrome [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for ultrasound and EMG guided Botox injections in non-relaxing puborectalis syndrome has terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-relaxing Puborectalis Syndrome

Drugs mentioned

• Botox (OnabotulinumtoxinA)

Snippet

Sponsor: Karen Noblett | Conditions: Non-relaxing Puborectalis Syndrome | Phase 2, Phase 3 | Status: TERMINATED | Results posted: 2021-11-03